Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2006

FR Doc E6-13221 [Federal Register: August 14, 2006 (Volume 71, Number 156)] [Notices] [Page 46514-46515] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr14au06-94]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 31, 2006, Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes

[[Page 46515]]

of controlled substances listed in Schedule I and II:

Drug  Schedule 
Methcathinone (1237)  I
N-Ethylamphetamine (1475)  I
N,N-Dimethylamphetamine (1480)  I
4-Methylaminorex (cis isomer) (1590)  I
Alpha-Ethyltryptamine (7249)  I
Lysergic acid diethylamide (7315)  I
2, 5-dimethoxy-4-n)-propylthiophenethylamine (2C-T-7) (7348)  I
Tetrahydrocannabinols (7370)  I
Mescaline (7381)  I
4-Bromo-2,5-dimethoxyamphetamine (7391)  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)  I
4-Methyl-2,5-dimethoxyamphetamine (7395)  I
2,5-Dimethoxyamphetamine (7396)  I
2-5-Dimethoxy-4-ethylamphetamine (7399)  I
3,4-Methylenedioxyamphetamine (7400)  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)  I
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)  I
4-Methoxyamphetamine (7411)  I
Alpha-methyltryptamine (AMT) (7432)  I
Bufotenine (7433)  I
Diethyltryptamine (7434)  I
Dimethyltryptamine (7435)  I
Psilocybin (7437)  I
Psilocyn (7438)  I
5-methoxy-N-,N-diisopropyltryptamine (5-MeO-DIPT) (7439)  I
N-Ethyl-1-phenylcyclohexylamine (7455)  I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy)(7458)  I
1[1-(2 Thienyl)cyclohexyl] piperidine (7470) I
Dihydromorphine (9145)  I
Normorphine (9313)  I
Methamphetamine (1105)  II
1-Phenylcylohexylamine (7460)  II
Phencyclidine (7471)  II
Phenylacetone (8501)  II
1-Piperidinocyclohexanecarbo nitrile (8603) II
Cocaine (9041)  II
Codeine (9050)  II
Dihydrocodeine (9120)  II
Benzoylecgonine (9180)  II
Ethylmorphine (9190)  II
Meperidine intermediate-B (9233)  II
Morphine (9300)  II
Noroxymorphone (9668)  II

The company plans to manufacture high purity drug standards used for analytical application only in clinical, toxicological and forensic laboratories.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than October 13, 2006.

Dated: July 26, 2006.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E6-13221 Filed 8-11-06; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility